Patents by Inventor Mitsuaki Yamamoto

Mitsuaki Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11668708
    Abstract: A method for avoiding the influence of a blood sample on a measurement error in a latex agglutination immunoassay. The measurement error caused by a blood sample in a latex agglutination immunoassay can be reduced by a method which includes a step of bringing the sample into contact, in a liquid phase, with latex particles carrying a substance having a specific affinity for an analyte in the presence of imidazole.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: June 6, 2023
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Kengo Fujimura, Junichi Kondou, Mitsuaki Yamamoto
  • Publication number: 20230003746
    Abstract: The present invention addresses the problem of providing a method for measuring 25-hydroxy vitamin D and a measurement reagent, the method and the reagent being based on a competitive immunoassay. The present invention provides a reagent for measuring 25-hydroxy vitamin D based on a competitive immunoassay, which includes at least the following composition: (1) a Vitamin D derivative represented by the chemical formula (I) and/or (II), (2) an anti-25 hydroxy vitamin D antibody. In addition, the present invention provides a reagent for measuring vitamin D based on a competitive latex turbidimetric immunoassay (competitive LTIA) in which, in particular, a vitamin D derivative or an anti-25-hydroxy vitamin D antibody is immobilized on latex.
    Type: Application
    Filed: November 20, 2020
    Publication date: January 5, 2023
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mitsuaki YAMAMOTO, Mieko OTA, Tomohisa NISHIO
  • Publication number: 20220187323
    Abstract: The problem to be solved by the present invention is to provide a reagent that can reduce deposition of fouling in the reaction cell, by using an existing reaction cell, without affecting the composition of the reagent, in an immunoassay method using a reagent containing latex particles; and to provide an immunoassay method using the reagent. Provided is an immunoassay reagent including a latex particle, wherein the latex particle contains a halogen atom. Also provided is an immunoassay method including contacting a latex particle with a sample to be measured in a reaction cell, wherein the latex particle contains a halogen atom.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 16, 2022
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mieko OTA, Yuuya INABA, Hiroki KOBAYASHI, Mitsuaki YAMAMOTO
  • Publication number: 20220187287
    Abstract: Disclosed is a sensitized magnetic responsive particle including: a magnetic responsive particle having a core particle and at least one magnetic layer that is disposed on the core particle and includes microparticles of a magnetic metal and/or an oxide thereof; and a substance that is supported on the magnetic responsive Particle and interacts specifically with an analyte, wherein the coefficient of variation in the weight-average particle size of the magnetic responsive particles is 15% or less. The magnetic responsive particle provided has excellent magnetic separability.
    Type: Application
    Filed: March 25, 2020
    Publication date: June 16, 2022
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Maasa YAJI, Yuya INABA, Shinichiro KITAHARA, Mitsuaki YAMAMOTO, Takeshi WAKIYA, Mai YAMAGAMI, Shuhei OBINATA
  • Patent number: 11275085
    Abstract: A problem of the present invention is to provide an immunochromatographic test strip avoiding agglutination of colloidal gold while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a hemagglutinating agent and the colloidal gold conjugates as a detection reagent, and to provide immunochromatography using the test strip. To solve the problem, the present inventors reviewed the composition of the existing reagent itself from a completely different viewpoint rather than the selection of type or amount of polyanions, and as a result of extensive study on each element, the inventors surprisingly found that agglutination of colloidal gold may be suppressed by using a particular additive without neutralization by polyanions.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: March 15, 2022
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Keigo Kohno, Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Marie Asami
  • Publication number: 20220033048
    Abstract: A ballast water treatment system includes: a chemical agent container for containing a chemical agent for a ballast water treatment; a chemical liquid preparation tank having a tank main body for containing the chemical agent supplied from the chemical agent container and water for dissolving the chemical agent, and a mixture part for mixing the chemical agent with the water in the tank main body; a chemical liquid storage tank for storing the chemical liquid obtained by dissolving the chemical agent in the water in the chemical liquid preparation tank; and a chemical liquid supply part for supplying the chemical liquid stored in the chemical liquid storage tank into ballast water.
    Type: Application
    Filed: December 26, 2019
    Publication date: February 3, 2022
    Applicant: Kuraray Co., Ltd.
    Inventors: Koji YAMAMOTO, Mitsuaki YAMAMOTO, Takeshi MATSUDA
  • Publication number: 20210389306
    Abstract: A problem to be solved is to provide a glycated hemoglobin (%) assay method and assay reagent capable of accurate measurement of glycated hemoglobin (%) in blood even when a blood specimen containing hemoglobin contains abnormal hemoglobin such as HbS or HbC. The present invention provides a method capable of accurate measurement of glycated hemoglobin (%) in blood even in a specimen containing abnormal hemoglobin by combining two types of monoclonal antibodies, i.e., an anti-glycated hemoglobin monoclonal antibody and a monoclonal antibody to the anti-glycated hemoglobin monoclonal antibody, and an assay reagent for performing the method.
    Type: Application
    Filed: September 27, 2019
    Publication date: December 16, 2021
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mieko OTA, Osamu MIYAZAKI, Satoko SEO, Mitsuaki YAMAMOTO, Tomohisa NISHIO
  • Publication number: 20200232977
    Abstract: The present invention is directed to a method for avoiding the influence of a blood sample on a measurement error in a latex agglutination immunoassay. The measurement error caused by a blood sample in a latex agglutination immunoassay can be reduced by a method which includes a step of bringing the sample into contact, in a liquid phase, with latex particles carrying a substance having a specific affinity for an analyte in the presence of imidazole.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 23, 2020
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Kengo FUJIMURA, Junichi KONDOU, Mitsuaki YAMAMOTO
  • Publication number: 20200130802
    Abstract: Disclosed herein is a ballast water treatment device including a bypass pipe having both ends connected to a ballast pipe which is connected to a ballast tank and through which ballast water flows, the bypass pipe being configured to allow a part of ballast water flowing through the ballast pipe to form a divided flow from the ballast pipe and to allow the divided flow to be merged with the ballast pipe, a chemical holding part in which a chemical is stored and a chemical pipe configured to connect the chemical holding part and the bypass pipe with each other and supplies the chemical from the chemical holding part to the ballast pipe.
    Type: Application
    Filed: March 8, 2018
    Publication date: April 30, 2020
    Applicant: Kuraray Co., Ltd.
    Inventors: Koji YAMAMOTO, Mitsuaki YAMAMOTO, Takeshi MATSUDA
  • Publication number: 20200081002
    Abstract: A problem of the present invention is to provide an immunochromatographic test strip avoiding agglutination of colloidal gold while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a hemagglutinating agent and the colloidal gold conjugates as a detection reagent, and to provide immunochromatography using the test strip. To solve the problem, the present inventors reviewed the composition of the existing reagent itself from a completely different viewpoint rather than the selection of type or amount of polyanions, and as a result of extensive study on each element, the inventors surprisingly found that agglutination of colloidal gold may be suppressed by using a particular additive without neutralization by polyanions.
    Type: Application
    Filed: August 13, 2019
    Publication date: March 12, 2020
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Keigo KOHNO, Mayumi YOSHIDA, Mitsuaki YAMAMOTO, Shinya YOKOKAWA, Marie ASAMI
  • Patent number: 10500527
    Abstract: A ballast water production method is provided. The method includes a filtering step that passes raw water supplied into a housing through a filter from a primary side that is upstream of the filter to a secondary side that is downstream of the filter; a volume-increasing step after the filtering step that increases a volume of water present in a space on the secondary side of the housing while the supply of the raw water into the housing is stopped; a pressurizing step after the volume-increasing step that pressurizes an inside of the housing from the secondary side while the supply of the raw water into the housing is stopped; and a rinsing step after the pressurizing step that passes a fluid through the filter from the secondary side to the primary side while the supply of the raw water into the housing is stopped.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: December 10, 2019
    Assignee: KURARAY CO., LTD.
    Inventors: Mitsuaki Yamamoto, Kazuaki Hagiwara, Yasuhiro Tajima
  • Publication number: 20190331700
    Abstract: A method of lipid assay characterized by assaying the lipids contained in a blood component in the presence of an organic silicon compound. The method can cause specific conditions for direct methods while satisfying requirements such as no influence on precision of assay, no burden on assay apparatus, and easy availability.
    Type: Application
    Filed: May 13, 2019
    Publication date: October 31, 2019
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mitsuaki YAMAMOTO, Shoko YAMAMOTO, Mitsuhiro NAKAMURA, Kazunori SAITO
  • Patent number: 10422799
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: September 24, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono
  • Patent number: 10422790
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventors reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventors surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: September 24, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono
  • Patent number: 10422798
    Abstract: A problem of the present invention is to provide an immunochromatographic test strip avoiding agglutination of colloidal gold while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a hemagglutinating agent and the colloidal gold conjugates as a detection reagent, and to provide immunochromatography using the test strip. To solve the problem, the present inventors reviewed the composition of the existing reagent itself from a completely different viewpoint rather than the selection of type or amount of polyanions, and as a result of extensive study on each element, the inventors surprisingly found that agglutination of colloidal gold may be suppressed by using a particular additive without neutralization by polyanions.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: September 24, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Keigo Kohno, Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Marie Asami
  • Patent number: 10416156
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: September 17, 2019
    Assignee: SEKISUI MEDICAL CO., LTD.
    Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono
  • Patent number: 10151747
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: December 11, 2018
    Assignee: Sekisui Medical Co., Ltd.
    Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono
  • Publication number: 20180267033
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Application
    Filed: December 19, 2017
    Publication date: September 20, 2018
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mayumi YOSHIDA, Mitsuaki YAMAMOTO, Shinya YOKOKAWA, Tomo SHIMIZU, Keigo KONO
  • Publication number: 20180246090
    Abstract: An object of the present invention is to provide a more accurate and sensitive measurement method lowering the possibility of occurrence of nonspecific reaction in immunological measurement of L-FABP. More specifically, an object is to provide a measurement method that is accurate and sensitive even when the concentration of an analyte is low (e.g., an L-FABP concentration is around the normal value). In an immunological measurement method of L-FABP using an anti-L-FABP antibody, nonspecific reaction can easily be suppressed by a polypeptide consisting of amino acids No. 419 to No. 607 of the amino acid sequence of DnaK, a heat shock protein (HSP), derived from E. coli as set forth in SEQ ID NO: 1 or a polypeptide having at least 90% sequence identity with the polypeptide even in highly sensitive measurement.
    Type: Application
    Filed: February 25, 2016
    Publication date: August 30, 2018
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Koji KOBAYASHI, Takuji MATSUMOTO, Mitsuaki YAMAMOTO
  • Publication number: 20180120303
    Abstract: A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 3, 2018
    Applicant: SEKISUI MEDICAL CO., LTD.
    Inventors: Mayumi Yoshida, Mitsuaki Yamamoto, Shinya Yokokawa, Tomo Shimizu, Keigo Kono